Showing results (211-220 of 538) with videos related to

Sort By:
Pageof 54
RMD Open|April 5, 2016
Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritisPeter P Cheung, Karine Mari, Valérie Devauchelle-Pensec, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Association of Anti-Porphyromonas gingivalis Antibody Titers With Nonsmoking Status in Early Rheumatoid Arthritis: Results From the Prospective French Cohort of Patients With Early Rheumatoid ArthritisRaphaèle Seror, Sandrine Le Gall-David, Martine Bonnaure-Mallet, et al.
Arthritis and Rheumatism|July 9, 2003
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacyJacques-Eric Gottenberg, Florence Merle-Vincent, Fabrice Bentaberry, et al.
Arthritis and Rheumatism|January 13, 2011
B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label studyJérémie Sellam, Houria Hendel-Chavez, Stéphanie Rouanet, et al.
Clinical Rheumatology|April 12, 2019
Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION studyRieke Alten, Xavier Mariette, Hanns-Martin Lorenz, et al.
Arthritis Research & Therapy|September 5, 2015
Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS studyRaphaèle Seror, Gaétane Nocturne, Thierry Lazure, et al.
Rheumatology (Oxford, England)|December 23, 2021
Features of non-Hodgkin's lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren's syndrome patientsSimon Parreau, Gaétane Nocturne, Xavier Mariette, et al.
Arthritis Research & Therapy|March 8, 2007
CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndromeJacques-Eric Gottenberg, Pascale Loiseau, Mariam Azarian, et al.
Clinical Rheumatology|February 22, 2019
Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION studyRieke Alten, Xavier Mariette, Hanns-Martin Lorenz, et al.
Arthritis and Rheumatism|July 1, 2009
The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndromeCorinne Miceli-Richard, Nicolas Gestermann, Marc Ittah, et al.
Pageof 54